Kalyra Pharmaceuticals

Business Services · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

10835 Road to the Cure Ste 205, San Dieg...

Phone Number

(858) 263-4333

Revenue

$6.8 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Kalyra Pharmaceuticals

Kalyra Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on creating best-in-class medicines that address unmet needs in the area of pain management, anti-infectives and fibrosis. We aim to improve patient outcomes by developing modified molecules that retain the efficacy of commonly used medications while reducing or eliminating unwanted side effects and safety concerns. Our proprietary chemistry based platform has proven successful in generating an effective pain medication while eliminating an existing safety concern.Explore more
Kalyra Pharmaceuticals's Social MediaPopular SearchesKalyra Pharmaceuticals IncKalyra PharmaceuticalsKALYRA - PharmaceuticalsKalyra Pharmaceuticals LLCKalyra Pharmaceuticals| LLCSIC Code 87,873NAICS Code 54,541Show more

Kalyra Pharmaceuticals Org Chart

PhoneEmail
NF
United States flag for contact location.

Director, Residential Services

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
MS
United States flag for contact location.

Manager, Hospitality Services

PhoneEmail
KP
United States flag for contact location.

Senior Manager, Residential Services

PhoneEmail
DS
United States flag for contact location.

Building Works Manager

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Kalyra Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Kalyra Pharmaceuticals

Compare insights from companies similar to Kalyra Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Kalyra Pharmaceuticals

$6.8M
11-50
Private
$6.2M
2012
NF
Natasha ForwardDirector, Residential Services
$6.7M
11-50
Private
$74.8M
2006
N/A
<$5M
1-10
Private
$20.3M
2006
<$5M
11-50
Private
<$5M
2020
Francisco Torres, Chief Financial Officer at Forte Bio-Pharma
Francisco TorresChief Financial Officer
<$5M
1-10
Private
<$5M
2017
DW
Darren WolfeVice President, Clinical Operations
<$5M
1-10
Private
-
2007
PK
Prasanth KlSenior Validation Engineer
<$5M
11-50
Private
-
2005
RD
Rhonda DonahoeChief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Kalyra Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Kalyra Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kalyra Pharmaceuticals.

Kalyra Pharmaceuticals financials insights

Gather financial insights about Kalyra Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2013

Private Equity

$6.2M

See All Kalyra Pharmaceuticals's Financials Insights

Kalyra Pharmaceuticals Tech Stack

A closer look at the technologies used by Kalyra Pharmaceuticals

Top Business Services Companies

Frequently Asked Questions Regarding Kalyra Pharmaceuticals

What is Kalyra Pharmaceuticals's official website?
Kalyra Pharmaceuticals's official website is www.kalyrapharma.com
What is Kalyra Pharmaceuticals's Revenue?
Kalyra Pharmaceuticals's revenue is $6.8 Million
What is Kalyra Pharmaceuticals's SIC code?
Kalyra Pharmaceuticals's SIC: 87,873
What is Kalyra Pharmaceuticals's NAICS code?
Kalyra Pharmaceuticals's NAICS: 54,541
How many employees does Kalyra Pharmaceuticals have?
Kalyra Pharmaceuticals has 11-50 employees
What industry does Kalyra Pharmaceuticals belong to?
Kalyra Pharmaceuticals is in the industry of: Business Services, Research & Development
What is Kalyra Pharmaceuticals competition?
Kalyra Pharmaceuticals top competitors include: Pinnacle Pharmaceuticals, Vapogenix, Forte Bio-Pharma, TheraVida
What technology does Kalyra Pharmaceuticals use?
Some of the popular technologies that Kalyra Pharmaceuticals uses are: WordPress.org, PHP, Barracuda Networks, Google Font API
How do I contact Kalyra Pharmaceuticals?
Kalyra Pharmaceuticals contact info: Phone number: (858) 263-4333 Website: www.kalyrapharma.com
What does Kalyra Pharmaceuticals do?

Kalyra Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on creating best-in-class medicines that address unmet needs in the area of pain management, anti-infectives and fibrosis. We aim to improve patient outcomes by developing modified molecules that retain the efficacy of commonly used medications while reducing or elim... inating unwanted side effects and safety concerns. Our proprietary chemistry based platform has proven successful in generating an effective pain medication while eliminating an existing safety concern.Read More

What are Kalyra Pharmaceuticals social media links?
Kalyra Pharmaceuticals Linkedin page
Is Kalyra Pharmaceuticals a public company?
Kalyra Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about Kalyra Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.